Abstract
The thrombotic microangiopathic diseases, which include acquired and congenital TTP and HUS, are most frequently acute disease entities. Untreated, these diseases are associated with a lethal course in many cases. Deficiency of the von Willebrand cleaving enzyme, ADAMTS13, is a decisive pathophysiological defect in most cases of thrombotic microangiopathic diseases. Early recognition and a secure distinction from other conditions that resemble TMA diseases is essential in order to institute adequate treatment and to obtain a favourable outcome in terms of both survival and development of serious sequelae
Udgivelsesdato: 2009/11/30
Udgivelsesdato: 2009/11/30
Originalsprog | Dansk |
---|---|
Tidsskrift | Ugeskrift for læger |
Vol/bind | 171 |
Udgave nummer | 49 |
Sider (fra-til) | 3614-3620 |
Antal sider | 6 |
ISSN | 0041-5782 |
Status | Udgivet - 2009 |